Healthx, Inc. – Trademark Portfolio
Entity Type: 03
Healthx, Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 8 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include HEALTHX. The owner is based in Indianapolis, IN.
Suite 150
9339 Priority Way West
Indianapolis, IN 46240
Showing of trademarks Trademarks
Trademark Classifications
Healthx, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Healthx, Inc. have?
Healthx, Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned, 6 cancelled.
What trademark classes does Healthx, Inc. file in?
Healthx, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 9 (Computers & Electronics), Class 36 (Insurance & Financial). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Healthx, Inc.'s most well-known trademarks?
Healthx, Inc.'s registered trademark portfolio includes well-known marks such as HEALTHX. These are among 2 currently registered trademarks in the portfolio.
What is Healthx, Inc.'s trademark registration success rate?
Healthx, Inc. has a 18% trademark registration rate, with 2 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.